UH - UNIVERSITY HOSPITAL
1. Target Overview & Investment Thesis
UH - UNIVERSITY HOSPITAL is a 358-bed suburban community hospital in ESSEX, NJ with $702.0M in net patient revenue and a -27.5% operating margin. The hospital serves a payer mix of 9.9% Medicare, 11.3% Medicaid, and 78.8% commercial.
Thesis: Undervalued. Our ML models identify $51.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -27.5% to -20.1% (+736bps).
| Net Revenue HCRIS | $702.0M |
| Current EBITDA COMPUTED | $-192.9M |
| Operating Margin COMPUTED | -27.5% |
| Occupancy HCRIS | 86.6% |
| Revenue / Bed COMPUTED | $2.0M |
| Net-to-Gross HCRIS | 21.7% |
| Distress Probability ML | 39.6% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of -27.5% places it below the state median. Among 45 size-comparable peers (179-716 beds), the median margin is -3.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (179-716), prioritizing same-state peers. 45 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| UH - UNIVERSITY HOSPITAL (Target) | NJ | 358 | $702.0M | -27.5% |
| MORRISTOWN MEDICAL CENTER | NJ | 705 | $1.70B | 10.3% |
| COOPER UNIVERSITY HOSPITAL | NJ | 580 | $1.43B | 2.0% |
| ROBERT WOOD JOHNSON UNIVERSITY | NJ | 639 | $1.41B | -4.0% |
| JERSEY SHORE UNIVERSITY MED CT | NJ | 604 | $1.17B | 8.4% |
| COOPERMAN BARNABAS MEDICAL CEN | NJ | 554 | $1.07B | -4.3% |
| ENGLEWOOD HOSPITAL & MED CTR | NJ | 292 | $967.3M | 0.1% |
| WEST JERSEY HEALTH SYSTEM | NJ | 587 | $958.4M | 7.1% |
| THE VALLEY HOSPITAL | NJ | 385 | $951.8M | 17.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $51.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $14.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $14.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $13.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $8.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $449K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-192.9M |
| + RCM Uplift | +$51.7M |
| Pro Forma EBITDA | $-141.2M |
| Current Margin | -27.5% |
| Pro Forma Margin | -20.1% |
| WC Released (1x) | $26.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-296.8M | $-755.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-296.8M | $-927.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-267.1M | $-853.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-267.1M | $-1.01B | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-326.5M | $-917.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-326.5M | $-1.12B | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 45 hospitals with 179-716 beds
- Same-state prioritization (n=46)
- Comp margins: P25=-10.8% / P50=-3.1% / P75=2.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.